Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202898016 | Sulfabenzamide + sulfacetamide + sulfathiazole 184mg/143.75mg/172.5mg tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1478919010 | Sulfabenzamide+sulfacetamide+sulfathiazole 184mg/143.75mg/172.5mg tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3227031000052116 | sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Is a | Product containing sulfacetamide (medicinal product) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Is a | Product containing sulfathiazole (medicinal product) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Is a | Product containing sulfabenzamide (medicinal product) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Has active ingredient | Sulfabenzamide (substance) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Has active ingredient | Sulfacetamide (substance) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Has active ingredient | Sulfathiazole (substance) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Is a | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| sulfabensamid 184 mg + sulfacetamid 143,75 mg + sulfatiazol172,5 mg, tablett | Has manufactured dose form | Vaginal dose form (dose form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR